Authors:
Kaplan, SL
Patterson, L
Edwards, KM
Azimi, PH
Bradley, JS
Blumer, JL
Tan, TQ
Lobeck, FG
Anderson, DC
Citation: Sl. Kaplan et al., Linezolid for the treatment of community-acquired pneumonia in hospitalized children, PEDIAT INF, 20(5), 2001, pp. 488-494
Authors:
Lin, FYC
Philips, JB
Azimi, PH
Weisman, LE
Clark, P
Rhoads, GG
Regan, J
Concepcion, NF
Frasch, CE
Troendle, J
Brenner, RA
Gray, BM
Bhushan, R
Fitzgerald, G
Moyer, P
Clemens, JD
Citation: Fyc. Lin et al., Level of maternal antibody required to protect neonates against early-onset disease caused by group B streptococcus type Ia: A multicenter, seroepidemiology study, J INFEC DIS, 184(8), 2001, pp. 1022-1028
Authors:
Lin, FYC
Brenner, RA
Johnson, YR
Azimi, PH
Philips, JB
Regan, JA
Clark, P
Weisman, LE
Rhoads, GG
Kong, FH
Clemens, JD
Citation: Fyc. Lin et al., The effectiveness of risk-based intrapartum chemoprophylaxis for the prevention of early-onset neonatal group B streptococcal disease, AM J OBST G, 184(6), 2001, pp. 1204-1210
Authors:
Lin, FYC
Azimi, PH
Weisman, LE
Philips, JB
Regan, J
Clark, P
Rhoads, GG
Clemens, J
Troendle, J
Pratt, E
Brenner, RA
Gill, V
Citation: Fyc. Lin et al., Antibiotic susceptibility profiles for group B streptococci isolated from neonates, 1995-1998, CLIN INF D, 31(1), 2000, pp. 76-79
Authors:
Azimi, PH
Barson, WJ
Janner, D
Swanson, R
Citation: Ph. Azimi et al., Efficacy and safety of ampicillin/sulbactam and cefuroxime in the treatment of serious skin and skin structure infections in pediatric patients, PEDIAT INF, 18(7), 1999, pp. 609-613